DNA and mRNA vaccine Phase 1 candidates
25 years of bioengineering, innovation development, regulatory and clinical affairs, product launch, VC and executive experience.
co-inventor of MACH-1 technology, formerly at PowderJect, UW Professor, the lab focuses on NA vaccines for multiple pathogens.
co-founder and SAB member, UW, molecular and computational approaches vaccine design, the originator of conserved element (CE) approach to vaccine development.
15 years in NA vaccine field, developed genetic adjuvant platform at Profectus Biosciences, Inc.
Bioengineer, Immunology, and nano delivery system experience.
© 2020 Orlance, Inc.